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Hedgehog signaling is critical for correct embryogenesis and tissue development. However, on matu-
ration, signaling is also found to be aberrantly activated in many cancers. Palmitoylation of the secreted
signaling protein sonic hedgehog (Shh) by the enzyme hedgehog acyltransferase (Hhat) is required for
functional signaling. To quantify this important posttranslational modiﬁcation, many in vitro Shh pal-
mitoylation assays employ radiolabeled fatty acids, which have limitations in terms of cost and safety.
Here we present a click chemistry armed enzyme-linked immunosorbent assay (clickeELISA) for
assessment of Hhat activity through acylation of biotinylated Shh peptide with an alkyne-tagged pal-
mitoyl-CoA (coenzyme A) analogue. Click chemistry functionalization of the alkyne tag with azido-FLAG
peptide allows analysis through an ELISA protocol and colorimetric readout. This assay format identiﬁed
the detergent n-dodecyl b-D-maltopyranoside as an improved solubilizing agent for Hhat activity.
Quantiﬁcation of the potency of RU-SKI small molecule Hhat inhibitors by clickeELISA indicated IC50
values in the low- or sub-micromolar range. A stopped assay format was also employed that allows
measurement of Hhat kinetic parameters where saturating substrate concentrations exceed the binding
capacity of the streptavidin-coated plate. Therefore, clickeELISA represents a nonradioactive method for
assessing protein palmitoylation in vitro that is readily expandable to other classes of protein lipidation.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).tion; HTS, high-throughput
A, catalytic assay using an
A; HRP, horseradish peroxi-
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r Inc. This is an open access articlePosttranslational modiﬁcation (PTM) of proteins through S-
acylation of cysteine residues with predominantly C16:0 fatty acids
(termed palmitoylation) is one of the most common forms of PTM.
The palmitoyl acyltransferase family of proteins is associated with a
range of diseases, including neurological disorders and cancer [1].
Classically, protein lipidation has been studied through the appli-
cation of radiolabeled lipids to facilitate detection [2]. However,
such methods are limited in their utility due to requirements for
lengthy detection times, the hazards of using radioactive materials,
and the associated high costs of materials and disposal. With the
advent of the click chemistry era, the study of protein lipidation has
advanced signiﬁcantly. Here, fatty acids labeled with azide or
alkyne bioorthogonal reporters undergo copper(I)-catalyzed
[3 þ 2] cycloaddition for the attachment of reporter moieties.
Such reporters have allowed detailed analysis of lipidation through
a range of techniques, including Western blotting and in-gelunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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chemistry to in vivo studies is through afﬁnity enrichment and
proteomic analysis. This approach has identiﬁed changes in the N-
myristoylated proteome during the cell cycle and vertebrate
development [4,5] and has been applied to validate the lipid
transferase N-myristoyl transferase as an antimalarial drug target
in Plasmodium falciparum [6].
During recent years, click chemistry has also been applied to
in vitro studies of lipidation to afford a nonradioactive high-
throughput screen (HTS) format [7]. The enzyme ghrelin-O-acyl-
transferase (GOAT), which is responsible for the octanoylation of
the growth hormone releasing peptide ghrelin, was assessed
through a catalytic assay using an enzyme-linked click chemistry
assay (cateELCCA). A biotinylated substrate ghrelin peptide is
bound to a streptavidin-coated plate and incubated with GOAT-
containing membrane fractions and alkynyl-tagged n-octanoyl-
CoA (coenzyme A). The resulting alkynylated peptide is then sub-
jected to labeling via click chemistry with azido-HRP (horseradish
peroxidase) to facilitate product detection through ﬂuorogenic
deacetylation of Amplex Red in the presence of hydrogen peroxide
catalyzed by HRP [7]. This methodology allowed the assessment of
GOAT activity and measurement of kinetic parameters along with
screening to identify small molecule inhibitors [8].
Inspired by the success of the cateELCCA approach, we sought
to develop amethod tomeasure activity and kinetics of the enzyme
hedgehog acyltransferase (Hhat). Hhat is a multipass trans-
membrane protein [9,10] and, like GOAT and porcupine, is a
member of the membrane bound O-acyltransferase (MBOAT)
family of enzymes. MBOATs show similar topology in regions sur-
rounding conserved residues that are required for catalysis [11].
Hhat is responsible for the palmitoylation of sonic hedgehog (Shh),
a secreted morphogen that is involved in neurogenesis during
embryonic development and is aberrantly activated in mature tis-
sues leading to carcinogenesis [12,13]. Shh is palmitoylated via an
amide linkage on the N-terminal cysteine following signal peptide
cleavage, most likely by initial palmitoylation on the side chain of
the cysteine residue, with the palmitate group subsequently un-
dergoing an SeN acyl shift to the N-terminus [14]. Palmitoylation of
Shh has been shown to be essential for Shh signaling, thereby
making Hhat an attractive target for therapeutic intervention and
as a tool to investigate the hedgehog (Hh) pathway [15]. Indeed, a
class of 5-acyl-6,7-dihydrothieno[3,2-c]pyridines was recently
identiﬁed as inhibitors of Hhat using highly ionizing 125I-labeled
palmitoyl-CoA in a scintillation proximity assay HTS [16]. However,
contrary to the proposed therapeutic beneﬁt of Hh pathway inhi-
bition, several recent publications have demonstrated that forma-
tion of an Hh signaling promoted stromal matrix around tumors
actually results in restriction of tumor growth [17e19]. This dra-
matic contrast in the prognosis of Hh inhibition highlights the need
for better understanding of the Hh pathway, requiring both
improved assays and chemical tools. To date, many studies of Hhat
activity have employed radiolabeled palmitate [14,16,20e23],
which may impede both the analysis and development of existing
inhibitors and the identiﬁcation of new alternative series with
improved properties. To this end, we employed a click chemistry
armed enzyme-linked immunosorbent assay (clickeELISA) format
to study Hhat activity, kinetic parameters, and assessment of Hhat
inhibitors.
Materials and methods
Plasmid construction and cell culture
Human Hhat cDNA (accession number BC117130) base pairs 4 to
1479 was ampliﬁed by polymerase chain reaction (PCR) (forwardprimer: AGGAGATATACCATGCTGCCCCGATGGGAACTGG; reverse
primer: CAGAACTTCCAGTTTGTCCGTGGCGTAGGTCTGGGC) and
inserted by ligation independent In-Fusion cloning (Takara Bio/
Clontech, France) [24] into the expression vector, pOPINEneo-3C-
FLAG. This vector was produced by incorporating a C-terminal 3C
protease cleavage site, followed by a C-terminal FLAG and
8  histidine epitope into the plasmid, ptriex2neo (Novagen). The
human embryonic kidney 293a (HEK293a) line was transfected
with pOPINEneo-Hhat-3C-FLAG-His8 using TurboFect (Thermo
Scientiﬁc) according to the manufacturer's instructions. Single
colonies were ring cloned and selected for stable transfection
through culturing in Dulbecco's modiﬁed Eagle's medium (Invi-
trogen) supplemented with 9% fetal bovine serum (Invitrogen) and
500 mg/ml G418 (Sigma) for at least ﬁve passages. Resistant cells
were assessed by anti-polyhistidine immunoblotting, and the
highest expressing cell line was selected for further protein
expression. Cells were passaged as described previously [15].
Immunoblotting
Protein samples were supplemented with reducing NuPAGE
Sample Buffer (Fisher), separated by sodium dodecyl sulfa-
teepolyacrylamide gel electrophoresis (SDSePAGE) on a 15% gel,
and transferred to polyvinylidene diﬂuoride membranes (Milli-
pore). Membranes were blocked at room temperature (RT) for 1 h
in phosphate-buffered saline (PBS) with 5% skimmedmilk and then
incubated with a-polyhistidine-HRP monoclonal antibody (1:3000,
R&D Systems) for 16 h at 4 C. Bound immunocomplexes were
detected with ECL Plus (Pierce) and visualized on an Ettan DIGE
Imager (GE Healthcare). For normalization of Hhat concentration,
band intensities were quantiﬁed using ImageQuant software (GE
Healthcare).
Protein expression and solubilization
Buffers and conditions for Hhat expression and activity were
taken from existing literature protocols [14] with the following
modiﬁcations: HEK293a cells stably transfected with pOPINE-
Hhat-3C-FLAG-His8 were grown to 90% conﬂuence in 2  T175
ﬂasks, harvested via trypsinization, washed with 10 ml of 1  PBS,
and stored at 80 C. Pellets were lysed as described in the liter-
ature [14]. Unlysed cells were removed by centrifugation at 1000 rcf
for 10 min at 4 C, and the resulting supernatant was separated into
soluble (S100) and membrane (P100) fractions through centrifu-
gation at 100,000 rcf for 1 h at 4 C. The P100 fraction was resus-
pended in 8 ml of solubilization buffer (20 mM Hepes [pH 7.3],
350 mM NaCl, and 5% glycerol) supplemented with 1% (w/v)
detergent and incubated for 60 min on ice, followed by centrifu-
gation at 100,000 rcf for 1 h at 4 C to afford a solubilized mem-
brane fraction [P100(sol)] and nonsolubilized material [P100(n/
sol)], which were stored at 80 C.
Peptide and inhibitor synthesis
Heptadec-16-ynoic acid (YnC15) was synthesized according to
existing literature protocols [25,26] and coupled to CoA using 1,10-
carbonyl-diimidazole activation. 4-Azidobutyric acid was prepared
in two steps from ethyl 4-bromobutyrate. Residues 1 to 11 of the
mature Shh protein (CGPGRGFGKRK) were used as the substrate for
Hhat-catalyzed reactions, and Shh(1e11)-PEG3-biotin, YnC15-
Shh(1e11)-PEG3-biotin, and azido-FLAG (DYKDDDDK) peptides
were synthesized using standard solid phase peptide synthesis
protocols; full experimental information and characterization can
be found in the online supplementary material. Synthesis of RU-SKI
inhibitors was performed following our previously described
Fig.1. Comparison of enzyme-linked immunosorbent assay (ELISA) (A) and click
chemistry armed ELISA (clickeELISA) (B). (A) Analyte is captured on the plate and
detected with primary antibody, followed by secondary antibody-HRP conjugate.
Colorimetric readout is proportional to bound analyte. (B) Biotinylated substrate
modiﬁed with YnC15 alkyne tag is captured on a streptavidin-coated plate and func-
tionalized with FLAG-tag via copper(I)-catalyzed azide-alkyne cycloaddition (CuAAC).
FLAG-tag is detected by a-FLAG-HRP conjugate. Colorimetric readout is proportional to
alkyne-tagged substrate.
Fig.2. Solubilization of P100 membrane fractions. Total lysate (Tot. Lys.) was separated
into S100 and P100 fractions at 100,000 rcf for 1 h. P100 membranes were solubilized
in 1% (w/v) detergent for 1 h and then separated into P100(sol) and P100(n/sol)
fractions at 100,000 rcf for 1 h. Samples were separated by SDSePAGE and analyzed by
immunoblotting with a-polyhistidine-HRP. n-octyl b-D-glucopyranoside (OTG), Triton
X-100 (Triton), 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate
(CHAPS), and n-dodecyl b-D-maltopyranoside (DDM). Blot representative of three
separate experiments.
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[27]; full experimental information and characterization of the RU-
SKI inhibitors can be found in the associated Data in Brief article
[28].
ClickeELISA
Reacti-Bind streptavidin-coated clear wells (Fisher) were acti-
vated by washing with 3  200 ml of wash buffer (PBSeTween
20 þ 0.1% bovine serum albumin [BSA]), followed by 3  200 ml of
reaction buffer (100 mM MES [pH 6.5], 20 mM NaCl, 1 mM DTT
[dithiothreitol], and 0.1% [w/v] BSA). YnC15-CoA and Shh(1e11)-
biotin (in reaction buffer) were incubated with 10% (v/v) P100(sol)
fraction (~0.2 mg/ml) in a ﬁnal volume of 100 ml at RT in activated
streptavidin-coated wells. At the required time points, the well
contents were discarded and the wells were washed with
3  200 ml of wash buffer, followed by 3  200 ml of reaction buffer.
Wells were then labeled using 10 mM azido-FLAG peptide, 1 mM
CuSO4, 1 mM tris(2-carboxyethyl)phosphine (TCEP), and 1 mM tris
[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine (TBTA) in wash
buffer for 1 h at RT and subsequently washed with 3  200 ml of
wash buffer and 3 200 ml of reaction buffer. Afterward, wells were
probed with a-FLAG-HRP (1:20,000) (Sigma) in wash buffer for 1 h
at RT and then washed with 3  200 ml of wash buffer, followed by
3  200 ml of reaction buffer. a-FLAG-HRP (Sigma) was visualized
using BD OptEIA TMB reagent (Becton Dickinson) according to the
manufacturer's protocol. The development reactionwas stopped by
the addition of 50 ml 1 M H2SO4. Wells were read for optical density
at 450 nm on a BioTek PowerWave XS Microplate
Spectrophotometer.
IC50 values for RU-SKI inhibitors were measured over a six-log
unit serial dilution from 100 mM, corrected for background
against heat-inactivated P100(sol) low control, and normalized to
DMSO (dimethyl sulfoxide) vehicle-only high control.
For stopped assay conditions, reaction mixes were prepared as
stated previously in 1.5-ml microfuge tubes. At the required time
points, the Hhat-catalyzed reaction was stopped by the addition of
10 ml of 10% (w/v) SDS. The reaction mixtures were transferred to
activated streptavidin-coated wells and incubated for 45 min at RT.
Well contents were then discarded, wells were washed as
described previously, and the level of Shh(1e11)-acylation was
assessed via clickeELISA. Kinetic parameters were measured at
saturating concentrations of 5.0 mM YnC15-CoA and 3.0 mM
Shh(1e11) peptide and were corrected for background signal from
heat-inactivated P100(sol).
Results and discussion
Increase in solubilized Hhat activity due to n-dodecyl b-D-
maltopyranoside
ELISAs employ an immobilized antigen that is probed with an
antibody, and subsequently an antibody-HRP conjugate, to allow
the determination of levels of bound antigen through colorimetric
readout (Fig. 1A). By analogy, the clickeELISA format employed an
immobilized Shh(1e11) substrate peptide that was acylated by
Hhat using the alkynyl-tagged palmitoyl-CoA analogue YnC15-CoA.
The alkynylated peptide was then subjected to copper(I)-catalyzed
click reaction functionalization with azido-FLAG peptide to ligate a
FLAG tag. Subsequent probing with a-FLAG-HRP allowed determi-
nation of the level of Hhat-catalyzed Shh(1e11) labeling through
colorimetric readout using the TMB reaction (Fig. 1B).
Literature for the isolation of active Hhat fractions indicates that
n-octyl b-D-glucopyranoside (OTG) affords maximal Shh palmitoy-
lation activity [14]; however, our initial experiments following theseprotocols did not afford a high level of Shh(1e11) acylation (data not
shown). To increase the palmitoylation activity of Hhat, alternative
detergents were investigated for their ability to fully solubilize Hhat
in P100 membranes while maintaining enzymatic activity. Isolated
P100 membrane fractions from HEK293a cells stably expressing
Hhat-FLAG-His8 were resuspended in solubilization buffer con-
taining either 1% (w/v) Triton X-100, OTG, 3-[(3-cholamidopropyl)
dimethylammonio]-1-propanesulfonate (CHAPS), or n-dodecyl b-D-
maltopyranoside (DDM) and incubated for 1 h on ice. The extent of
Hhat solubilization was compared by a-His immunoblotting of
solubilized [P100(sol)] and nonsolubilized [P100(n/sol)] material
(Fig. 2). Hhat was detected in the P100 fraction and absent in the
S100 fraction. All detergents afforded high levels of solubilization,
with only CHAPS showing appreciable retention of Hhat in the
P100(n/sol) fraction.
The corresponding acylation activities of the detergent-
solubilized P100(sol) fractions were measured using the
clickeELISA format (Table 1). Moderate levels of acylation were
observed from nonsolubilized P100 membranes or from OTG
P100(sol) fractions. However, 2- and 5-fold increases in Shh(1e11)
palmitoylation were observed from CHAPS and DDM P100(sol)
fractions, respectively. No palmitoylation of Shh(1e11) peptide was
Table 1
Acylation activity of lysate fractions and P100(sol) fractions solubilized in the
presence of different detergents.
Fraction OD450 Relative activity (%)
P100 0.24 ± 0.03 27 ± 1
S100 0.05 ± 0.00 2 ± 1
P100(Triton) 0.07 ± 0.01 1 ± 1
P100(OTG) 0.21 ± 0.07 18 ± 7
P100(CHAPS) 0.37 ± 0.09 41 ± 6
P100(DDM) 0.76 ± 0.14 100
DDM buffer 0.06 ± 0.01 0
Relative activity is background corrected to DDM buffer signal and reported as
percentage relative to P100(DDM) signal. Detergent abbreviations are as described
in Fig. 2. Values represent means ± standard errors. Assays were performed in
duplicate, n ¼ 2.
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the Triton X-100 P100(sol). These ﬁndings are consistent with the
absence of Hhat in these fractions or the denaturing nature of
Triton X-100. Subsequent experiments, therefore, employed DDM-
solubilized P100(sol) fractions as a crude source of Hhat.Fig.3. Determination of clickeELISA parameters. All assays were performed at a total
Shh(1e11) peptide concentration of 1 mM. Alkynylated Shh(1e11) peptides were click
chemistry functionalized with 10 mM azido-FLAG, 1 mM CuSO4, 1 mM TCEP, and 1 mM
TBTA for 1 h unless otherwise stated. FLAG-labeled Shh(1e11) was detected with a-
FLAG-HRP at 1:20,000 dilution for 1 h unless otherwise stated. TMB reactions were
developed for 10 min unless otherwise stated. (A) TMB development reaction time
course of YnC15-Shh(1e11) (0.4 mM) in the presence of Shh(1e11) (0.6 mM). Assays
were performed in duplicate, n ¼ 3. (B) a-FLAG-HRP binding time course of YnC15-
Shh(1e11) (0.1 mM) in the presence of Shh(1e11) (0.9 mM) (n ¼ 3). (C) Click reaction
time course of YnC15-Shh(1e11) (0.1 mM) in the presence of Shh(1e11) (0.9 mM) (n ¼ 3).
(D) P100(sol)-catalyzed acylation of Shh(1e11) (1 mM) in the presence of YnC15-CoA
(1 mM). Assays were performed in duplicate, n ¼ 3.Development of an in vitro clickeELISA to measure Shh(1e11)
palmitoylation by Hhat
Having identiﬁed conditions that increased Hhat acylation ac-
tivity, assay parameters were validated to ensure that they were
within required ranges by using the synthetic product peptide,
YnC15-Shh(1e11)-PEG3-biotin. YnC15-Shh(1e11) peptide (0.4 mM)
was processed via clickeELISA, and the TMB development reaction
was measured as a function of time, indicating linearity to
OD450 ~ 2.00 (Fig. 3A). Binding of a-FLAG-HRP to 0.1 mM FLAG
functionalized YnC15-Shh(1e11) product peptide was investigated
as a function of time by discarding well contents at required time
points and was found to be complete within 1 h of incubation
(Fig. 3B). Likewise, click chemistry functionalization of 0.1 mM
YnC15-Shh(1e11) peptidewith azido-FLAGwas completewithin 1 h
(Fig. 3C).
Prior to use in enzymatic reactions, Hhat levels in DDM-
solubilized P100(sol) fractions were normalized by a-poly-
histidine immunoblotting and densitometry measurement to ac-
count for variation in expression and solubilization. The extent of
Shh(1e11) acylation catalyzed by approximately 2 mg P100(sol) was
measured against time, which indicated the rate of palmitoylation
to be essentially linear over 30 min (Fig. 3D).Assessment of small molecule inhibition of Hhat
To assess the suitability of the clickeELISA for inhibition studies,
the most active Hhat inhibitors described in the literature were
tested for their effect on Shh(1e11) acylation [16,29]. The RU-SKI
class of inhibitors are based on a 5-acyl-6,7-dihydrothieno[3,2-c]
pyridine core (Fig. 4) and were synthesized via our previously re-
ported synthetic strategy [27]. Full synthetic details of the RU-SKI
inhibitors are provided in the associated Data in Brief article [28].
RU-SKI 41, 43, 101, and 201 were assayed over a six-log unit serial
dilution from 100 mM, with all inhibitors achieving complete inhi-
bition of Hhat at 100 mM (see Fig. S1 in supplementary material).
IC50 values were calculated to be in the low- or sub-micromolar
range (Fig. 4). This ﬁnding is in agreement with literature data for
these compounds [29]. RU-SKI 201 displayed the highest potency,
and RU-SKI 43 displayed the lowest potency, for Hhat inhibition of
the compounds tested.Determination of kinetic parameters for Shh(1e11) acylation
Literature indicates that Hhat possesses lower afﬁnity for its
palmitoyl-CoA and Shh substrates than GOAT for its corresponding
octanoyl-CoA and ghrelin substrates. GOAT, as assessed by
cateELCCA, exhibits a Km of 67.5 nM for Oct-CoA and a Km of
99.8 nM for ghrelin [7]. Hhat has a reported Km of 1.25 mM for
palmitoyl-CoA and a reported Km of 3.0 mM for Shh [14]. To deter-
mine apparent Km values in a two-substrate system, one substrate
must be at saturating concentration while the reaction rate in
response to the second substrate concentration is assessed.
Therefore, determining kinetic parameters for Hhat necessitated
measuring enzyme activity at Shh(1e11) concentrations above the
biotin-binding capacity of currently available streptavidin-coated
plates (1.25 mM).
The assay format, therefore, was modiﬁed to measure Hhat-
catalyzed palmitoylation of Shh(1e11) above plate-saturating
concentrations. Hhat-catalyzed reactions were performed in
microfuge tubes followed by subsequent capturing of a represen-
tative proportion of the reaction mixture on the streptavidin-
coated plate for analysis. To stop Hhat-catalyzed lipidation prior
to plate binding, SDS was added to a ﬁnal concentration of 0.9% (w/
v), which would halt the Hhat-catalyzed reaction while not dis-
rupting the biotinestreptavidin interaction.
Fig.4. Structures of RU-SKI inhibitors and activity as assessed by clickeELISA. In-
hibitors were synthesized as described in the supplementary material and were
assayed over a six-log unit serial dilution from 100 mM. Samples were background
corrected against heat-inactivated P100(sol) low control and normalized to vehicle-
only high control. Assays were performed in duplicate, n ¼ 3.
Fig.5. Validation of SDS stop conditions for clickeELISA kinetic analysis. The
clickeELISA protocol was performed as described in Fig. 3. (A) Plate binding time
course for YnC15-Shh(1e11) (0.1 mM) and Shh(1e11) (0.9 mM) in the presence of 0.9%
SDS. Assays were performed in duplicate, n ¼ 3. (B) ClickeELISA signal in the presence
of varying total peptide concentrations of 40% YnC15-Shh(1e11)/Shh(1e11) mixture in
the presence of 0.9% SDS. Assays were performed in duplicate, n ¼ 3. (C) P100(sol)-
catalyzed acylation of Shh(1e11) (1 mM) in the presence of YnC15-CoA (1 mM)
stopped by the addition of SDS to 0.9% (10%, w/v, 10 ml). Assays were performed in
duplicate, n ¼ 3.
Table 2
Vmax and apparent Km values for YnC15-CoA and Shh(1e11) substrates assessed by
clickeELISA at 3.0 mM Shh(1e11) and 5.0 mM YnC15-CoA, respectively.
Substrate Vmax (pmol/min) Apparent Km (mM)
Shh(1e11) 1.08 ± 0.06 1.37 ± 0.25
YnC15-CoA 0.87 ± 0.06 0.15 ± 0.05
Values represent means ± standard errors. Assays were performed in duplicate:
Shh(1e11), n ¼ 3; YnC15-CoA, n ¼ 4.
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streptavidin-coated plate in the presence of 0.9% SDS was allowed
to proceed for speciﬁed time periods, and then well contents were
discarded and wells were analyzed by clickeELISA. The corre-
sponding data indicated that plate binding in the presence of 0.9%
SDS was essentially completed within 45 min (Fig. 5A). To deter-
mine whether both substrate and product biotinylated peptides
had equal afﬁnity for streptavidin-coated wells, and therefore
would allow capture of a representative proportion of the reaction
mixture, the synthetic product and substrate peptides were pre-
pared in a 1.0:1.5 molar ratio, respectively. Total peptide concen-
trations ranging from 0.5 to 10 mMwere prepared in the presence of
0.9% SDS, added to streptavidin-coated wells, and allowed to bind
for 45 min prior to analysis. Above a total peptide concentration of
1.25 mM, the stated plate binding capacity, the OD450 signal
remained constant, which indicated a proportional capture of the
productesubstrate mixture (Fig. 5B). It should be noted that the
peptide sequence affected the streptavidin capture rate because
alkynyl-tagged biotinylated peptides with different sequences did
not afford representative capture of mixtures with Shh(1e11)
substrate peptide (data not shown). The ability of 0.9% SDS to halt
Hhat-catalyzed acylation was tested by the addition of the deter-
gent to enzyme reactions at required time points, followed by in-
cubation in streptavidin-coated wells for 45 min and analyzing
wells as described previously. The data indicated a linear reaction
rate over 30 min, as demonstrated previously (Fig. 5C).
Kinetic analysis of the Hhat-containing P100(sol) fractions was
performed by using the SDS stop conditions and proportional
capture of the reaction mixture. The level of YnC15-Shh(1e11)
formed in the Hhat-catalyzed reaction was calibrated against a
standard curve generated from serial dilution of synthetic YnC15-
Shh(1e11) peptide. At 3.0 mM Shh(1e11) peptide, YnC15-CoA was
found to have a Vmax of 0.87 ± 0.06 pmol/min and an apparent Km of
0.15 ± 0.05 mM (see Fig. S2A in supplementary material). At 5.0 mM
YnC15-CoA, the Shh(1e11) peptide was found to have a Vmax of
1.08 ± 0.06 pmol/min and an apparent Km of 1.37 ± 0.25 mM (Table 2
and Fig. S2B).Conclusions
Click chemistry-based methods have greatly advanced under-
standing of Shh lipidation [9,30,31]. In the current study, we have
developed a click chemistry-based ELISA format for measuring
Hhat-catalyzed acylation of Shh (residues 1e11) using an alkyne-
tagged palmitoyl-CoA substrate. Alkynylated product peptides
were functionalized via click chemistry with azido-FLAG and then
probed with a-FLAG-HRP to allow colorimetric readout of
Shh(1e11) palmitoylation. Detergent screening using this assay
format identiﬁed DDM as a superior solubilizing agent to OTG for
Hhat activity, affording a 5-fold increase in acylation activity
(Table 1), due to themilder disruptive effect onmembranes of DDM
compared with OTG [32]. Therefore, DDM should be adopted for
future studies of solubilized Hhat activity. The clickeELISA format
was successfully applied to quantify Hhat inhibition by small
T. Lanyon-Hogg et al. / Analytical Biochemistry 490 (2015) 66e72 71molecules and has also been employed to investigate the activity of
various Hhat point mutants [9]. Furthermore, the assay protocol
was developed to allow the screening of biotinylated substrate
concentrations above the assay plate binding capacity by using
stopped reaction conditions and proportional sampling of the
substrateeproduct mixture.
The apparent Km for Shh(1e11) of DDM-solubilized P100(sol)
fractions was in agreement with literature values of OTG-
solubilized Hhat (1.37 and 1.25 mM, respectively). In contrast, the
apparent Km for YnC15-CoA of DDM-solubilized P100(sol) fractions
was lower than literature values for the apparent Km for [125I]
iodopalmitoyl-CoA of OTG-solubilized Hhat (0.15 and 3.0 mM,
respectively) (Table 2 and Fig. S2) [14]. The stopped reaction pro-
tocol renders the assay applicable to kinetic assessment of systems
with higher Km values and, thus, expands the repertoire of enzymes
that may be assayed by click chemistryeELISA formats. The use of
stopped assay conditions allows assessment of enzyme kinetics in
solution phase, which avoids issues associated with using solid
supported substrates (e.g., substrates bound to streptavidin-coated
plates or beads). Solid supported substrates can interfere with
enzyme kinetics because the substrate is not free to diffuse in so-
lution, resulting in areas of increased local substrate concentration.
In addition, the presence of the solid support itself may serve to
attract or repel the enzyme, or hinder access to the substrate,
thereby altering reaction rates. In solution phase studies, there is an
even concentration of free substrate and the enzyme can be
assumed to followMichaeliseMenten kinetics. SDS stop conditions
provide an effective means to access solution phase kinetic studies
because streptavidin is unusual among proteins in its ability to
tolerate high SDS concentrations while maintaining an active
conformation.
Because the presented assay format employs alkynylated rather
than radiolabeled lipids, it offers signiﬁcant advantages in terms of
safety, cost, and synthetic accessibility of substrate compounds for
future lipidation investigations. The click chemistry armed
enzyme-linked immunosorbent assay format, therefore, represents
a powerful and versatile tool for in vitro studies of lipidation of
peptide substrates by MBOAT enzymes.Acknowledgments
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